the infamous patients who were found to have no drug in their systems at the end of the Assure trial, yet were counted as contributors of data in the final tally. It would be assumed that these patients never took any 208 during the course or the latter part of the trial. It made no sense why they had to be included to the lay person then or now, but then again at times, one can't let common sense get in the way of stupidity.

This was discussed on the boards years ago.  Yes it sucks, but it's FDA policy and there are good reasons for keeping those folks in the data analysis.

"....This guidance is intended for sponsors, clinical investigators and institutional review boards (IRBs).  It describes the Food and Drug Administration’s (FDA) longstanding policy that already-accrued data, relating to individuals who cease participating in a study, are to be maintained as part of the study data...."

https://www.fda.gov/downloads/regulatoryinformation/guidances/ucm126489.pdf